The number of deals announced in the global healthcare sector (including pharmaceuticals and medical equipment) grew by 18.1% during the week ended May 3, 2020 compared to the previous week, according to GlobalData’s deals database.
Aurojyoti Bose, Lead Analyst at GlobalData, comments: “The healthcare sector has been relatively resilient compared to other sectors and this is the third consecutive week of growth in deal activity amidst uncertainty and volatile market conditions due to the COVID-19 outbreak.”
Deal activity increased in key markets such as the US, China and the UK during the week ended May 3, 2020 compared to the previous week, while Canada and South Korea witnessed decline.
Venture financing, mergers and acquisitions (M&A), equity offerings and licensing agreement deals increased by 18.4%, 6.3%, 20.0% and 44.4%, respectively, during the week ended May 3, 2020 compared to the previous week, while partnership deal volume declined.
For more information
To gain access to our latest press releases: GlobalData Media Centre
Analysts available for comment. Please contact the GlobalData Press Office:
EMEA & Americas: +44 (0)207 936 6400
Asia-Pacific: +91 40 6616 6809
- Quotes are provided by Aurojyoti Bose, Lead Analyst at GlobalData
- Information based on GlobalData’s Financial Deals Database
- This press release was written using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by GlobalData’s team of industry experts
4,000 of the world’s largest companies, including over 70% of FTSE 100 and 60% of Fortune 100 companies, make timelier and better business decisions thanks to GlobalData’s unique data, expert analysis and innovative solutions, all in one platform. GlobalData’s mission is to help our clients decode the future to be more successful and innovative across a range of industries, including the healthcare, consumer, retail, financial, technology and professional services sectors.